鳥居薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/02/14 | 2,756 | 2,857 | 2,750 | 2,834 | -371 | -11.6% | 275,600 |
2022/02/10 | 3,190 | 3,235 | 3,145 | 3,205 | +35 | +1.1% | 111,700 |
2022/02/09 | 3,200 | 3,200 | 3,115 | 3,170 | +5 | +0.2% | 62,400 |
2022/02/08 | 3,200 | 3,220 | 3,155 | 3,165 | +25 | +0.8% | 42,800 |
2022/02/07 | 3,095 | 3,220 | 3,095 | 3,140 | +30 | +1% | 70,300 |
2022/02/04 | 3,050 | 3,150 | 3,030 | 3,110 | +80 | +2.6% | 116,000 |
2022/02/03 | 2,916 | 3,080 | 2,906 | 3,030 | +112 | +3.8% | 165,800 |
2022/02/02 | 2,854 | 2,925 | 2,830 | 2,918 | +79 | +2.8% | 57,400 |
2022/02/01 | 2,854 | 2,866 | 2,820 | 2,839 | -10 | -0.4% | 45,800 |
2022/01/31 | 2,848 | 2,863 | 2,814 | 2,849 | +7 | +0.2% | 31,000 |
2022/01/28 | 2,853 | 2,854 | 2,818 | 2,842 | +32 | +1.1% | 24,500 |
2022/01/27 | 2,887 | 2,887 | 2,776 | 2,810 | -63 | -2.2% | 46,600 |
2022/01/26 | 2,892 | 2,900 | 2,850 | 2,873 | -16 | -0.6% | 27,900 |
2022/01/25 | 2,907 | 2,938 | 2,859 | 2,889 | -18 | -0.6% | 63,000 |
2022/01/24 | 2,759 | 2,915 | 2,759 | 2,907 | +147 | +5.3% | 95,700 |
2022/01/21 | 2,731 | 2,761 | 2,694 | 2,760 | +29 | +1.1% | 35,200 |
2022/01/20 | 2,750 | 2,779 | 2,731 | 2,731 | +7 | +0.3% | 17,800 |
2022/01/19 | 2,775 | 2,775 | 2,708 | 2,724 | -96 | -3.4% | 47,800 |
2022/01/18 | 2,870 | 2,870 | 2,811 | 2,820 | -40 | -1.4% | 15,200 |
2022/01/17 | 2,875 | 2,894 | 2,839 | 2,860 | -18 | -0.6% | 17,700 |
2022/01/14 | 2,887 | 2,887 | 2,842 | 2,878 | -12 | -0.4% | 19,300 |
2022/01/13 | 2,910 | 2,945 | 2,882 | 2,890 | -20 | -0.7% | 27,200 |
2022/01/12 | 2,845 | 2,926 | 2,845 | 2,910 | +65 | +2.3% | 37,200 |
2022/01/11 | 2,853 | 2,879 | 2,822 | 2,845 | -8 | -0.3% | 29,300 |
2022/01/07 | 2,871 | 2,883 | 2,839 | 2,853 | -17 | -0.6% | 15,900 |
2022/01/06 | 2,885 | 2,922 | 2,870 | 2,870 | -30 | -1% | 17,000 |
2022/01/05 | 2,930 | 2,958 | 2,876 | 2,900 | -25 | -0.9% | 27,300 |
2022/01/04 | 2,898 | 2,933 | 2,871 | 2,925 | +47 | +1.6% | 29,300 |
2021/12/30 | 2,912 | 2,919 | 2,865 | 2,878 | -78 | -2.6% | 39,800 |
2021/12/29 | 2,956 | 2,956 | 2,895 | 2,956 | +126 | +4.5% | 60,200 |
2021/12/28 | 2,828 | 2,850 | 2,810 | 2,830 | +11 | +0.4% | 88,400 |
2021/12/27 | 2,807 | 2,822 | 2,783 | 2,819 | +9 | +0.3% | 50,500 |
2021/12/24 | 2,830 | 2,850 | 2,783 | 2,810 | -27 | -1% | 41,600 |
2021/12/23 | 2,831 | 2,842 | 2,749 | 2,837 | -38 | -1.3% | 74,500 |
2021/12/22 | 2,866 | 2,885 | 2,850 | 2,875 | +9 | +0.3% | 26,100 |
2021/12/21 | 2,875 | 2,875 | 2,847 | 2,866 | -1 | ±0% | 31,600 |
2021/12/20 | 2,881 | 2,881 | 2,847 | 2,867 | -14 | -0.5% | 30,900 |
2021/12/17 | 2,880 | 2,909 | 2,865 | 2,881 | -16 | -0.6% | 32,900 |
2021/12/16 | 2,897 | 2,901 | 2,857 | 2,897 | +35 | +1.2% | 32,500 |
2021/12/15 | 2,889 | 2,900 | 2,847 | 2,862 | -17 | -0.6% | 26,600 |
2021/12/14 | 2,860 | 2,883 | 2,836 | 2,879 | +34 | +1.2% | 30,600 |
2021/12/13 | 2,834 | 2,864 | 2,810 | 2,845 | +15 | +0.5% | 34,100 |
2021/12/10 | 2,870 | 2,870 | 2,817 | 2,830 | -27 | -0.9% | 40,500 |
2021/12/09 | 2,886 | 2,912 | 2,842 | 2,857 | -34 | -1.2% | 23,900 |
2021/12/08 | 2,875 | 2,912 | 2,833 | 2,891 | +45 | +1.6% | 51,500 |
2021/12/07 | 2,826 | 2,860 | 2,816 | 2,846 | +31 | +1.1% | 60,400 |
2021/12/06 | 2,813 | 2,830 | 2,778 | 2,815 | +23 | +0.8% | 35,300 |
2021/12/03 | 2,757 | 2,817 | 2,757 | 2,792 | +48 | +1.7% | 21,100 |
2021/12/02 | 2,692 | 2,770 | 2,684 | 2,744 | +33 | +1.2% | 55,000 |
2021/12/01 | 2,745 | 2,754 | 2,703 | 2,711 | -67 | -2.4% | 39,600 |
801~
850
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
ペプチド | 167,300円 | +5.0% | +1.5% | 0.00% | 14.31倍 | 3.81倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
キッセイ薬 | 385,500円 | +3.6% | +6.1% | 3.11% | 12.99倍 | 0.76倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
科研薬 | 373,800円 | -6.4% | -71.8% | 5.08% | 41.63倍 | 0.93倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 299,500円 | +7.9% | -3.3% | 2.67% | 8.33倍 | 0.86倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム